BioAtla (BCAB) Other Accumulated Expenses (2020 - 2026)

BioAtla's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $941000.0 for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 4.79% year-over-year to $941000.0 in Q1 2026; TTM through Mar 2026 was $941000.0, a 4.79% increase from a year earlier, with the FY2025 full-year figure at $879000.0, down 15.72% from the prior year.
• Other Accumulated Expenses rose to $941000.0 in Q1 2026 per BCAB's latest filing, from $879000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $1.8 million in Q2 2022 and bottomed at $509000.0 in Q3 2025.
• The 5-year median for Other Accumulated Expenses is $865000.0 (2023), against an average of $863941.2.
• Across the five-year window, Other Accumulated Expenses surged 181.49% in 2022 and slumped 50.59% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $1.3 million in 2022, then plunged by 32.37% to $865000.0 in 2023, then climbed by 20.58% to $1.0 million in 2024, then retreated by 15.72% to $879000.0 in 2025, then climbed by 7.05% to $941000.0 in 2026.
• Per Business Quant, the three latest BCAB Other Accumulated Expenses figures stand at $941000.0 (Q1 2026), $879000.0 (Q4 2025), and $509000.0 (Q3 2025).